This study estimates the economic returns that Global Fund-supported ARV therapy services and their associated health benefits can generate over the 11-year period 2011 to 2020. The presented new model quantifies economic returns by linking Global Fund grant delivery results with projections of the future costs of ARV therapy programs and of corresponding gains in patient survival and the economic value of life-years gained.
This report is based on a meeting held 5 December 2009 in Amsterdam, the Netherlands. The gathering, a “Strategy Meeting on a Global Campaign for a Currency Transaction Levy for Health”, was organised and hosted by a locally based non-governmental organization (NGO), International Civil Society Support (ICSS), and build on an initial meeting held in Washington DC in the summer of 2009.
As the meeting’s title implies, it aimed to broaden and deepen civil society engagement in a campaign for the implementation of a currency transaction levy (CTL), a particularly promising innovative financing mechanism that could raise billions of dollars for global health needs.
This report is based on a meeting held on 13 and 14 July 2009 in Washington, DC. Organized and hosted jointly by the International HIV/AIDS Alliance (IHAA), International Civil Society Support (ICSS) and RESULTS, the meeting aimed to develop strategies to increase support for, and the ultimate implementation of, a currency transaction levy (CTL) whose revenues would be used to expand and improve global health. The overall goal was to inaugurate a new civil society-led campaign for a CTL for health.
Funded by RESULTS Educational Fund and supported by: RESULTS International · Health GAP ∙ Global AIDS Alliance ∙ Global Health Advocates ∙ Advocates for Youth · Ecumenical Advocacy Alliance ∙ Project RING – Japan AIDS & Society Association
The Global Fund (GF) estimates that in order to reach universal access to HIV/AIDS prevention, treatment and care by 2010 and achieve the MDG for AIDS, TB and malaria by 2015, it will need up to US$11 billion per year by 2010 – over a five-fold increase from current spending. This assumes a steady scaling up of resources starting with US$3 billion in 2006, US$5billion in 2007 and US$7, 9 and 11 billion for 2008, 2009 and 2010 respectively. US$11 billion is the GF’s share of the total annual resource needs of US$23 billion for HIV/AIDS, US$4.5 billion for TB and US$3.7 billion for malaria by 2010. Significant scale-up in GF resources will need to be financed primarily by donor countries. This report card grades major d...